Thor Medical ASA (OSL: TRMED)

Thor Medical ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	29.6	41.77	98.72
Cash & Short-Term Investments	29.6	41.77	98.72
Cash Growth	-	-57.69%	-
Other Receivables	4.1	2.9	3.18
Receivables	4.1	2.9	3.18
Prepaid Expenses	-	0.43	0.88
Other Current Assets	-	0.25	6.34
Total Current Assets	33.7	45.35	109.11
Property, Plant & Equipment	1.9	1.01	0.54
Goodwill	-	37.22	-
Long-Term Deferred Charges	-	247.27	-
Total Assets	320.1	330.84	109.65
Accounts Payable	3	2.1	9.09
Accrued Expenses	-	1.61	4.92
Current Portion of Leases	0.4	-	0.16
Current Income Taxes Payable	-	-	0.76
Other Current Liabilities	1.8	0.73	29.36
Total Current Liabilities	5.2	4.45	44.28
Long-Term Deferred Tax Liabilities	54.4	54.46	-
Total Liabilities	60.1	58.91	45.8
Common Stock	47	46.71	23.21
Additional Paid-In Capital	61.5	246.07	66.55
Retained Earnings	-33.9	-20.85	-28.43
Comprehensive Income & Other	185.4	-	2.51
Shareholders' Equity	260	271.93	63.84
Total Liabilities & Equity	320.1	330.84	109.65
Total Debt	0.9	-	0.16
Net Cash (Debt)	28.7	41.77	98.56
Net Cash Growth	-	-57.62%	-
Net Cash Per Share	0.12	0.24	0.86
Filing Date Shares Outstanding	234.86	233.54	115.13
Total Common Shares Outstanding	234.86	233.54	115.13
Working Capital	28.5	40.9	64.83
Book Value Per Share	1.11	1.16	0.55
Tangible Book Value	-24.5	234.71	63.84
Tangible Book Value Per Share	-0.10	1.01	0.55
Machinery	-	4.93	10.85

Source: S&P Capital IQ. Standard template. Financial Sources.